GRM5 and hepatocellular carcinoma: Moreover, inhibition of mGluR5 was shown to enhance the potency of chemotherapeutic agents in hepatocellular carcinoma cell lines and attenuate chemotoxicity over DNA damage by downregulating Ca2+-dependent MAPK signaling in the normal liver (76).